Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$9.59 - $11.35 $28,539 - $33,777
-2,976 Reduced 1.43%
205,363 $2.02 Million
Q2 2023

Aug 15, 2023

SELL
$9.02 - $10.29 $94,971 - $108,343
-10,529 Reduced 4.81%
208,339 $2.08 Million
Q1 2023

May 11, 2023

BUY
$9.2 - $12.26 $168,350 - $224,345
18,299 Added 9.12%
218,868 $2.11 Million
Q4 2022

Feb 14, 2023

BUY
$8.72 - $11.56 $268,785 - $356,325
30,824 Added 18.16%
200,569 $2.23 Million
Q3 2022

Nov 07, 2022

BUY
$8.48 - $11.13 $425,204 - $558,080
50,142 Added 41.92%
169,745 $1.45 Million
Q2 2022

Aug 11, 2022

BUY
$9.95 - $12.27 $314,270 - $387,547
31,585 Added 35.88%
119,603 $1.25 Million
Q1 2022

May 04, 2022

BUY
$9.81 - $15.4 $182,152 - $285,947
18,568 Added 26.74%
88,018 $958,000
Q4 2021

Mar 08, 2022

BUY
$12.09 - $14.68 $839,650 - $1.02 Million
69,450 New
69,450 $940,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $11.5B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Arvest Trust CO N A Portfolio

Follow Arvest Trust CO N A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arvest Trust CO N A, based on Form 13F filings with the SEC.

News

Stay updated on Arvest Trust CO N A with notifications on news.